Literature DB >> 33556158

Response to Braillon.

Bernardo Bonanni1, Davide Serrano1, Patrick Maisonneuve2, Matteo Lazzeroni1, Powel H Brown3, Aliana Guerrieri-Gonzaga1, Eva Szabo4.   

Abstract

Entities:  

Year:  2021        PMID： 33556158      PMCID： PMC7853174          DOI： 10.1093/jncics/pkab005

Source DB:  PubMed          Journal:  JNCI Cancer Spectr        ISSN： 2515-5091


× No keyword cloud information.
  6 in total

1.  The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.

Authors:  Nicholas R Anthonisen; Melissa A Skeans; Robert A Wise; Jure Manfreda; Richard E Kanner; John E Connett
Journal:  Ann Intern Med       Date:  2005-02-15       Impact factor: 25.391

2.  Modulation by aspirin and naproxen of nucleotide alterations and tumors in the lung of mice exposed to environmental cigarette smoke since birth.

Authors:  Sebastiano La Maestra; Francesco D'Agostini; Alberto Izzotti; Rosanna T Micale; Luca Mastracci; Anna Camoirano; Roumen Balansky; James E Trosko; Vernon E Steele; Silvio De Flora
Journal:  Carcinogenesis       Date:  2015-10-13       Impact factor: 4.944

3.  Hospitalizations and mortality in the Lung Health Study.

Authors:  Nicholas R Anthonisen; John E Connett; Paul L Enright; Jure Manfreda
Journal:  Am J Respir Crit Care Med       Date:  2002-08-01       Impact factor: 21.405

4.  Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.

Authors:  John J McNeil; Mark R Nelson; Robyn L Woods; Jessica E Lockery; Rory Wolfe; Christopher M Reid; Brenda Kirpach; Raj C Shah; Diane G Ives; Elsdon Storey; Joanne Ryan; Andrew M Tonkin; Anne B Newman; Jeff D Williamson; Karen L Margolis; Michael E Ernst; Walter P Abhayaratna; Nigel Stocks; Sharyn M Fitzgerald; Suzanne G Orchard; Ruth E Trevaks; Lawrence J Beilin; Geoffrey A Donnan; Peter Gibbs; Colin I Johnston; Barbara Radziszewska; Richard Grimm; Anne M Murray
Journal:  N Engl J Med       Date:  2018-09-16       Impact factor: 91.245

5.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Authors:  Peter M Rothwell; F Gerald R Fowkes; Jill F F Belch; Hisao Ogawa; Charles P Warlow; Tom W Meade
Journal:  Lancet       Date:  2010-12-06       Impact factor: 79.321

Review 6.  Estimates of benefits and harms of prophylactic use of aspirin in the general population.

Authors:  J Cuzick; M A Thorat; C Bosetti; P H Brown; J Burn; N R Cook; L G Ford; E J Jacobs; J A Jankowski; C La Vecchia; M Law; F Meyskens; P M Rothwell; H J Senn; A Umar
Journal:  Ann Oncol       Date:  2014-08-05       Impact factor: 32.976
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.